NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) EBIT : $-0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group EBIT?

NP Life Sciences Health Industry Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-0.04 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NP Life Sciences Health Industry Group's annualized ROC % for the quarter that ended in Dec. 2023 was -1,200.10%. NP Life Sciences Health Industry Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. NP Life Sciences Health Industry Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.01%.

NP Life Sciences Health Industry Group EBIT Historical Data

The historical data trend for NP Life Sciences Health Industry Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group EBIT Chart

NP Life Sciences Health Industry Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-0.11

-0.13

-0.07

-0.02

NP Life Sciences Health Industry Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															0.02	-	0.07	-0.04	-0.04

Competitive Comparison of NP Life Sciences Health Industry Group's EBIT

For the Education & Training Services subindustry, NP Life Sciences Health Industry Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NP Life Sciences Health Industry Group's EV-to-EBIT Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, NP Life Sciences Health Industry Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NP Life Sciences Health Industry Group's EV-to-EBIT falls into.

NP Life Sciences Health Industry Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

NP Life Sciences Health Industry Group (OTCPK:NPLS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NP Life Sciences Health Industry Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-0.144 * ( 1 - 58.33% )	/	( (0.01	+	0)	/ 2 )
=	-0.0600048	/	0.005
=	-1,200.10 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.095	-	0.054	-	( 0.085	-	max(0, 0.064	-	0.095	+	0.085	))
=	0.01

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.077	-	0.038	-	( 0.071	-	max(0, 0.038	-	0.077	+	0.071	))
=	0

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

NP Life Sciences Health Industry Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.144	/	( ( (0 + max(-0.054, 0))	+	(0 + max(-0.032, 0)) )	/	2 )
=	-0.144	/	( ( 0	+	0 )	/	2 )
=	-0.144	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.01)	-	(0.054	+	0.01	+	0)
=	-0.054

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.006)	-	(0.038	+	0	+	0)
=	-0.032

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

NP Life Sciences Health Industry Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.001	/	15.632
	=	-0.01 %

NP Life Sciences Health Industry Group EBIT Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506

Website

https://www.gjcc.us

NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.

Executives

Guidong Wang	director, 10 percent owner, officer: Chairman, CEO. Pres, Treas	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg	director	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang	director, officer: CEO, President and Treasurer	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu	director, 10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang	10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines